Di‐n‐butyl phthalate (DBP) is included on the List of Priority Substances to be assessed under the Canadian Environmental Protection Act. Based on available data, DBP is “unclassifiable with respect to carcinogenicity in humans”. The estimated total average daily intakes of DBP for the various age groups in the general population in Canada, based on limited data, are 13 to 33 times less than the tolerable daily intake derived on the basis of data from bioassays in animal species.
No takes yet. Share an insight, caveat, or question.
Chan et al. (1994) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: